News & Events
How to Decide if Watchful Waiting is the Right Choice
A new tool helps remove the emotion around choosing the right approach for prostate cancer
The Benefits of Exercise during Pregnancy
Women who exercise during pregnancy are more likely to deliver vaginally than those who do not, and show no greater risk of preterm birth.
Nanodomains of Reactive Oxygen Species Control Mitochondrial Energy Output
Using a new tool, researchers can study localized reactive oxygen species signals that control mitochondrial function in health and disease
Jefferson and Aria Come Together; Combination Further Drives Transformation of Region’s Health Care
Jefferson and Aria Health today announced they have completed their transaction, giving greater reach to Jefferson’s transformative model of delivering more value to patients by providing the right care, at the right place and the right time in the communities it serves.
New Pathway to Treat Heart Failure
Researchers discover a new way to keep the heart pumping, which could lead to new drugs for heart disease.
Patients with Inflammation More Likely to Develop Diabetes after Transplant
A new study in kidney transplant recipients suggests that patients with more inflammation prior to surgery are more likely to develop diabetes than those with less overall inflammation.
Natural Molecule Could Improve Parkinson’s
A natural molecule shows benefit in a preliminary clinical trial for Parkinson’s disease
A Broken Calorie Sensing Pathway: How Overeating May Lead to More Eating
New research shows that overeating reduces levels of a hormone that signals the feeling of fullness in the brain, potentially promoting more eating.
Jefferson Receives $2 Million from Philanthropist and Real Estate Developer Steven H. Korman to Fund New Community Engagement Center
Thomas Jefferson University is proud to announce a $2 million gift from Steven H. Korman to fund the creation of the Steven H. Korman Center for Community Engagement.
Blood-born Molecules Could Predict Those Who Will Develop Liver Cancer
A panel of microRNAs from blood samples may predict patients at high risk of developing a common liver cancer from hepatitis B virus infection.